Video-head impulse test results in patients with Menière's disease related to duration and stage of disease
| Autor: | K. Abolhosseini, Tj. D. Bruintjes, Sylvia Masius-Olthof, P. P. G. van Benthem, H.J. van der Zaag-Loonen, B.F. van Esch |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Male
medicine.medical_specialty Time Factors Video Recording Disease 03 medical and health sciences vestibular hypofunction 0302 clinical medicine Internal medicine medicine Caloric Tests Video head impulse test Humans In patient Stage (cooking) Head Impulse Test Meniere Disease Retrospective Studies business.industry General Neuroscience Absolute risk reduction Head impulse test Meniere's disease Reflex Vestibulo-Ocular Middle Aged medicine.disease Sensory Systems Semicircular Canals Otorhinolaryngology Duration (music) Reflex caloric testing Female Neurology (clinical) Vestibule Labyrinth business 030217 neurology & neurosurgery |
| Zdroj: | Journal of Vestibular Research, 28(5-6), 401-407 |
| ISSN: | 1878-6464 |
| Popis: | BACKGROUND: The video-head impulse test employs the vestibulo-ocular reflex (VOR) to assess vestibular function. To this day, no consensus has been reached among scientists in terms of whether or not vHIT results change in MD patients as the disease progresses. OBJECTIVE: To assess whether the vHIT is more often abnormal in later stages of MD compared to earlier stages. METHODS: We retrospectively analyzed patients with 'definite' MD who had undergone a vHIT and caloric test between 2012 and 2015. Patients were evaluated based on duration of disease in years (≤1, >1≤5, >5≤10, >10) and stage of disease (stage I and II versus III and IV). For the vHIT, an abnormal vestibulo-ocular reflex was defined as a gain cut-off value of≤0.8 and presence of correction saccades including subanalyses using a cut-off value of≤0.9. RESULTS: In 89 definite MD patients (42 (47%) male, mean age 55±5 (SD)), data on both the caloric test and the vHIT were available. The risk of an abnormal vHIT was 25% in patients with a duration of disease over 10 years compared to 22% in the patients with a disease duration of 10 years or less (risk difference 3%, 95% CI:- 28% to 35%), p = 0.82). The risk for an abnormal vHIT in the Stage I and Stage II was 17% compared to 26% in Stage III and IV (risk difference 9%, 95% CI:- 30% to 11%). When using a cut-off value of 0.9 we also did not demonstrate a relationship between the duration of disease and the proportion of abnormal vHIT test results. CONCLUSIONS: There is no relationship between the proportion of abnormal vHIT test results in patients with MD in either duration or stage of disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|